Investing Profile

Aymeric Sallin

InvestorVCCEOFounder
Founder & CEO at NanoDimension
nd.capitalMenlo Park, California
Photo of Aymeric Sallin, Investor at NanoDimension
Your Intro Paths to Aymeric Sallin

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Aymeric Sallin on

cb
Current Investing Position
NanoDimension Investor
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
18
Current Fund Size
$500M

Aymeric Sallin is on these Sector & Stage Rankings

Therapeutics (Series B)Therapeutics (Series A)Therapeutics (Pre-seed)Therapeutics (Seed)Therapeutics (Series B)Therapeutics (Pre-seed)Digital Health (Pre-seed)Therapeutics (Series A)BioTech (Pre-seed)Therapeutics (Seed)Health IT (Pre-seed)Health & Hospital Services (Pre-seed)Digital Health (Series B)BioTech (Series B)Health & Hospital Services (Series B)Health IT (Series B)AI (Series B)Digital Health (Series A)AI (Pre-seed)Digital Health (Seed)BioTech (Series A)Digital Health (Pre-seed)Health & Hospital Services (Series A)BioTech (Seed)Health IT (Series A)BioTech (Pre-seed)Health & Hospital Services (Seed)Health IT (Seed)AI (Series A)San Francisco Bay AreaHealth & Hospital Services (Pre-seed)Health IT (Pre-seed)BioTech (Series B)AI (Series B)AI (Seed)Digital Health (Series B)Health & Hospital Services (Series B)Health IT (Series B)AI (Pre-seed)Health & Hospital Services (Series A)Digital Health (Series A)BioTech (Series A)Digital Health (Seed)AI (Series A)BioTech (Seed)Health IT (Series A)Health & Hospital Services (Seed)AI (Seed)Health IT (Seed)

Aymeric Sallin's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
H55
Series UnknownFeb 2018
Tarveda Therapeutics
Series DFeb 2017$30M
Series BJan 2015$21M
Series BDec 2013$21M
Series AJan 2012$3M
$110M
Co-investors: James Barrett, Frank Torti
Selecta Biosciences
Series ESep 2015$38M
Private EquityOct 2014$20M
Series CApr 2010$15M
Series BFeb 2009$15M
$150M
Co-investors: Carl Gordon (OrbiMed), Amir Nashat (Polaris Partners), Doug Cole (Flagship Ventures), Timothy A. Springer
Crocus Technology
Series EJun 2015$21M
Series DJul 2013$44M
Series CMay 2010$11M
Series BOct 2008$16M
$92M
View
Series UnknownNov 2013$13M
Series DJun 2012$55M
Series CDec 2010$40M
$200M
Co-investors: Samir Kaul (Khosla Ventures)
BIND Therapeutics
Series CJun 2010$12M
Series BNov 2007$16M
$31M
Co-investors: Amir Nashat (Polaris Partners), Amy Schulman (Polaris Partners), Scott Minick (ARCH Venture Partners), Noubar Afeyan (Flagship Ventures)